the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
Last Updated on November 28, 2015 by Joseph Gut – thasso November 28, 2015 – The American Food and Drug Administration (FDA) just approved Necitumumab (Portrazza) in combination with two forms of chemotherapy to treat patients with advanced (metastatic) squamous …
Last Updated on November 24, 2015 by Joseph Gut – thasso November 25, 2015 – Right in time for the upcoming holyday season, this post addresses once more the issue of tainted sexual enhancement products. Such products, bought over the …
Stiff Nights: Dangerously tainted sexual enhancement products are everywhere Read more »
Last Updated on November 22, 2015 by Joseph Gut – thasso November 21, 2015 – During the last few days, the American Food and Drug Administration (FDA) just extended the armamentarium in the fight against multiple myeloma by two new …
Last Updated on November 15, 2015 by Joseph Gut – thasso November 14, 2015 – The American Food and Drug Administration (FDA) just granted accelerated approval for an oral medication to treat patients with advanced non-small cell lung cancer (NSCLC). …
Last Updated on November 13, 2015 by Joseph Gut – thasso November 13, 2015 – The American Food and Drug Administration (FDA) just approved Cobimetinib (Cotellic) to be used in combination with Vemurafenib (Zelboraf) to treat advanced melanoma that has spread …
Last Updated on November 8, 2015 by Joseph Gut – thasso November 06, 2015 – Just about the same time at the End of October 2015, the American Drug and Food Administration (FDA) has approved, and the European Medicines Agency (EMA) has recommended …
Imlygic, a first-of-its-kind oncolytic immunotherapy for the treatment of melanoma Read more »